Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, March 2021

Altmetric Badge

Mentioned by

twitter: 1 X user

Citations

dimensions_citation: 3 Dimensions

Readers on

mendeley: 10 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 1 X post from an account with 33,509 followers.

See new results from a retrospective study on the clinical outcomes, safety, costs, and healthcare resource utilization in patients with metastatic #MerkelCellCarcinoma receiving #Immunotherapy or chemotherapy from a US hospital discharge database here: ht

24 Sep 2021

Reply Repost Favourite

Dove Medical Press

Article Metrics

Clinical Outcomes, Costs, and Healthcare Resource Utilization in Patients with Metastatic Merkel Cell Carcinoma Treated with Immune Checkpoint Inhibitors vs Chemotherapy

Mentioned by

Citations

Readers on